t500 bpc 157 BPC-157/TB-500 Capsules BPC-157 + TB-500 Combination: Benefits,

Research Dose Ranges Preclinical animal studies: 110 mcg/kg (nanogram to microgram range) once or twice daily Extrapolated human equivalent range commonly discussed in clinical literature: 200500 mcg/day Human pilot IV data: doses up to 20 mg were tolerated without adverse effects in two healthy adults (Lee & Burgess, 2025) though this is far above typical outpatient dosing Protocol: Musculoskeletal / Connective Tissue Healing For tendon, ligament, or muscle injury recovery, the standard approach in clinical functional medicine practice involves: SubQ injection at 200500 mcg once daily , injected near (not into) the injury site Cycle length: typically 48 weeks , with reassessment Often combined with TB-500 (thymosin beta-4) for synergistic tissue remodeling the BPC+TB stack Best results seen alongside physical therapy, not as a substitute for it Protocol: Gut and GI Mucosal Healing For IBD, gut permeability, NSAID damage, or H

A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment

There is theoretical concern about effects on cell proliferation, including potential influence on abnormal cell growth

The Research Profile section below details the mechanisms and the literature that frames each

Those on 10mg lost 21.4%